| Pharmacokinetic and pharmacodynamic properties of oral L‐citrulline and L‐arginine: impact on nitric oxide metabolism E Schwedhelm, R Maas, R Freese, D Jung, Z Lukacs, A Jambrecina, ... British journal of clinical pharmacology 65 (1), 51-59, 2008 | 606 | 2008 |
| Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community RH Böger, LM Sullivan, E Schwedhelm, TJ Wang, R Maas, EJ Benjamin, ... Circulation 119 (12), 1592-1600, 2009 | 442 | 2009 |
| Urinary 8-iso-Prostaglandin F2α as a Risk Marker in Patients With Coronary Heart Disease: A Matched Case-Control Study E Schwedhelm, A Bartling, H Lenzen, D Tsikas, R Maas, J Brümmer, ... Circulation 109 (7), 843-848, 2004 | 330 | 2004 |
| Comparative effects of AT1-antagonism and angiotensin-converting enzyme inhibition on markers of inflammation and platelet aggregation in patients with coronary artery disease B Schieffer, C Bünte, J Witte, K Hoeper, RH Böger, E Schwedhelm, ... Journal of the American College of Cardiology 44 (2), 362-368, 2004 | 329 | 2004 |
| Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay F Schulze, R Wesemann, E Schwedhelm, K Sydow, J Albsmeier, ... Clinical Chemistry and Laboratory Medicine (CCLM) 42 (12), 1377-1383, 2004 | 325 | 2004 |
| ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of l-arginine and B vitamins K Sydow, E Schwedhelm, N Arakawa, SM Bode-Böger, D Tsikas, ... Cardiovascular research 57 (1), 244-252, 2003 | 318 | 2003 |
| The role of asymmetric and symmetric dimethylarginines in renal disease E Schwedhelm, RH Böger Nature Reviews Nephrology 7 (5), 275-285, 2011 | 305 | 2011 |
| Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: results from the multicenter Coronary Artery Risk Determination investigating the … F Schulze, H Lenzen, C Hanefeld, A Bartling, KJ Osterziel, L Goudeva, ... American heart journal 152 (3), 493. e1-493. e8, 2006 | 293 | 2006 |
| The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function R Maas, E Schwedhelm, J Albsmeier, RH Böger Vascular Medicine 7 (3), 213-225, 2002 | 289 | 2002 |
| Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality—an update on patient populations with a wide range of cardiovascular risk RH Böger, R Maas, F Schulze, E Schwedhelm Pharmacological Research 60 (6), 481-487, 2009 | 246 | 2009 |
| Clinical pharmacokinetics of antioxidants and their impact on systemic oxidative stress E Schwedhelm, R Maas, R Troost, RH Böger Clinical pharmacokinetics 42, 437-459, 2003 | 239 | 2003 |
| Determination of a reference value for NG, NG‐dimethyl‐L‐arginine in 500 subjects F Schulze, R Maas, R Freese, E Schwedhelm, E Silberhorn, RH Böger European journal of clinical investigation 35 (10), 622-626, 2005 | 199 | 2005 |
| High-throughput liquid chromatographic-tandem mass spectrometric determination of arginine and dimethylated arginine derivatives in human and mouse plasma E Schwedhelm, R Maas, J Tan-Andresen, F Schulze, U Riederer, ... Journal of Chromatography B 851 (1-2), 211-219, 2007 | 188 | 2007 |
| Clopidogrel improves systemic endothelial nitric oxide bioavailability in patients with coronary artery disease: evidence for antioxidant and antiinflammatory effects T Heitzer, V Rudolph, E Schwedhelm, M Karstens, K Sydow, M Ortak, ... Arteriosclerosis, thrombosis, and vascular biology 26 (7), 1648-1652, 2006 | 182 | 2006 |
| Pathophysiology of isoprostanes in the cardiovascular system: implications of isoprostane‐mediated thromboxane A2 receptor activation J Bauer, A Ripperger, S Frantz, S Ergün, E Schwedhelm, RA Benndorf British journal of pharmacology 171 (13), 3115-3131, 2014 | 172 | 2014 |
| Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: an intriguing interaction with diabetes mellitus M Anderssohn, E Schwedhelm, N Lüneburg, RS Vasan, RH Böger Diabetes and Vascular Disease Research 7 (2), 105-118, 2010 | 166 | 2010 |
| Homoarginine Levels Are Regulated by l-Arginine:Glycine Amidinotransferase and Affect Stroke Outcome: Results From Human and Murine Studies C Choe, D Atzler, PS Wild, AM Carter, RH Böger, F Ojeda, O Simova, ... Circulation 128 (13), 1451-1461, 2013 | 165 | 2013 |
| Dimethylarginine dimethylaminohydrolase-1 is the critical enzyme for degrading the cardiovascular risk factor asymmetrical dimethylarginine X Hu, D Atzler, X Xu, P Zhang, H Guo, Z Lu, J Fassett, E Schwedhelm, ... Arteriosclerosis, thrombosis, and vascular biology 31 (7), 1540-1546, 2011 | 150 | 2011 |
| Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke F Schulze, AM Carter, E Schwedhelm, R Ajjan, R Maas, RA von Holten, ... Atherosclerosis 208 (2), 518-523, 2010 | 146 | 2010 |
| Telmisartan improves insulin sensitivity in nondiabetic patients with essential hypertension RA Benndorf, T Rudolph, D Appel, E Schwedhelm, R Maas, F Schulze, ... Metabolism 55 (9), 1159-1164, 2006 | 139 | 2006 |
